Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Say Beng Tan

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Clinical Trials (London, England)|November 11, 2005
Where's the utility in Bayesian data-monitoring of clinical trials?Deborah Ashby, Say-Beng Tan
Statistics in Medicine|July 12, 2002
Bayesian two-stage designs for phase II clinical trialsSay-Beng Tan, David Machin
Statistics in Medicine|July 19, 2006
Bayesian two-stage designs for phase II clinical trialsSay-Beng Tan, David Machin
Statistics in Medicine|August 15, 2006
Phase II trial designs in the presence of stratificationSay-Beng Tan, David Machin
Journal of Biopharmaceutical Statistics|December 30, 2011
Sample sizes for estimating differences in proportions--can we keep things simple?Sze Huey Tan, David Machin, Say Beng Tan
Annals of the Academy of Medicine, Singapore|January 16, 2007
The journal impact factor: too much of an impact?Tam Cam Ha, Say Beng Tan, Khee Chee Soo
Expert Review of Anticancer Therapy|March 11, 2010
Phase II clinical trials in oncology: are we hitting the target?Mei-Kim Ang, Say-Beng Tan, Wan-Teck Lim
Statistics in Medicine|July 14, 2005
A Bayesian dose finding design for dual endpoint phase I trialsYee-Chong Loke, Say-Beng Tan, YiYu Cai, et al.
Contemporary Clinical Trials|August 28, 2007
Can external and subjective information ever be used to reduce the size of randomised controlled trials?Say-Beng Tan, Joseph Wee, Hwee-Bee Wong, et al.
Computational and Mathematical Methods in Medicine|April 7, 2012
Comparing statistical models to predict dengue fever notificationsArul Earnest, Say Beng Tan, Annelies Wilder-Smith, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Clinical Trials (London, England)|November 11, 2005
Where's the utility in Bayesian data-monitoring of clinical trials?Deborah Ashby, Say-Beng Tan
Statistics in Medicine|July 12, 2002
Bayesian two-stage designs for phase II clinical trialsSay-Beng Tan, David Machin
Statistics in Medicine|July 19, 2006
Bayesian two-stage designs for phase II clinical trialsSay-Beng Tan, David Machin
Statistics in Medicine|August 15, 2006
Phase II trial designs in the presence of stratificationSay-Beng Tan, David Machin
Journal of Biopharmaceutical Statistics|December 30, 2011
Sample sizes for estimating differences in proportions--can we keep things simple?Sze Huey Tan, David Machin, Say Beng Tan
Annals of the Academy of Medicine, Singapore|January 16, 2007
The journal impact factor: too much of an impact?Tam Cam Ha, Say Beng Tan, Khee Chee Soo
Expert Review of Anticancer Therapy|March 11, 2010
Phase II clinical trials in oncology: are we hitting the target?Mei-Kim Ang, Say-Beng Tan, Wan-Teck Lim
Statistics in Medicine|July 14, 2005
A Bayesian dose finding design for dual endpoint phase I trialsYee-Chong Loke, Say-Beng Tan, YiYu Cai, et al.
Contemporary Clinical Trials|August 28, 2007
Can external and subjective information ever be used to reduce the size of randomised controlled trials?Say-Beng Tan, Joseph Wee, Hwee-Bee Wong, et al.
Computational and Mathematical Methods in Medicine|April 7, 2012
Comparing statistical models to predict dengue fever notificationsArul Earnest, Say Beng Tan, Annelies Wilder-Smith, et al.
Pageof 5